Daar Yossef 4
4 · CYABRA, INC. · Filed May 18, 2026
Research Summary
AI-generated summary of this filing
Cyabra (CYAB) CPO Daar Yossef Receives 130,000 RSU Award
What Happened
- Daar Yossef, Chief Product Officer and a director of Cyabra, Inc. (CYAB), was granted 130,000 restricted stock units (RSUs) on May 14, 2026. The Form 4 reports an acquisition (code A) at $0.00 per share (no dollar value reported on the form). Each RSU represents the right to receive one share of common stock upon vesting.
Key Details
- Transaction date: May 14, 2026 (Reported on Form 4 filed May 18, 2026) — filing appears timely.
- Transaction type/code: Award/Grant (A) — 130,000 RSUs.
- Reported price/value: $0.00 per RSU as shown on the filing (no total dollar value reported).
- Vesting schedule: Quarterly vesting of 26,000 shares through July 1, 2027 (per footnote).
- Shares owned after transaction: Not specified in the provided filing details.
- Footnote: RSUs issued under the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan; each RSU equals one share upon vesting.
- Filing timeliness: Period of report 2026-05-14, Form 4 filed 2026-05-18 — within the typical 2-business-day reporting window.
Context
- RSU grants are compensation awards that convert to shares only as they vest; they are not open-market purchases or sales and do not immediately change tradable float. Such awards are common for employee/director compensation and do not by themselves signal an insider buying or selling stock.
Insider Transaction Report
Form 4
CYABRA, INC.CYAB
Daar Yossef
DirectorChief Product Officer
Transactions
- Award
Common Stock
[F1]2026-05-14+130,000→ 840,549 total
Footnotes (1)
- [F1]On May 14, 2026, the Reporting Person was granted 130,000 restricted stock units ("RSUs") of the Issuer pursuant to the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan, vesting in quarterly amounts of 26,000 shares of common stock, par value $0.0001 per share (the "Common Stock") through July 1, 2027. Each RSU represents the right to receive one Common Stock.
Signature
/s/ Yael Sandler, Attorney-in-Fact|2026-05-18